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DOCTOR’S  ORDERS:  A  NEW  PRESCRIPTION  FOR
ADHD  MEDICATION  ABUSE
Erinn L. Rigney*
“Th[is] stuff [Adderall] is like an . . . anabolic steroid.”
—Mitch1
In a society that never stops, discovering a quick fix grants one an
immeasurable competitive edge whether it be in the academic or professional
arena.  The world of athletics has grappled with the use of anabolic steroids
for years, finally implementing anti-doping laws2 and strict guidelines for
athletes.  However, in the academic setting, a similar problem has arisen that
cannot be solved by random drug testing or other anti-doping mechanisms.
Since the genesis of ADD/ADHD in the early 1980s, affected individuals
have been able to procure medications that enhance cognitive capabilities: the
ability to focus, concentrate, and retain information.  Those truly suffering
from ADHD reap the benefits of these medications while many non-affected
people now acquire the drug for themselves to get ahead, primarily within
academic settings.  The prevalence of Adderall and the ease with which indi-
 2012 Erinn L. Rigney.  Individuals and nonprofit institutions may reproduce
and distribute copies of this Article in any format at or below cost, for educational
purposes, so long as each copy identifies the author, provides a citation to the Notre
Dame Law Review, and includes this provision in the copyright notice.
* J.D. Candidate, Notre Dame Law School, 2013; M.Ed., Loyola University
Chicago, 2006; B.A., University of Notre Dame, 2004.  I would like to thank Meghan
Rigney, my sister and Notre Dame Law School J.D. Candidate, 2015, for her
inspiration on the topic, Professor Leslie Callahan for her support and mentoring,
and the staff of the Notre Dame Law Review, In addition I would like to thank my father
Bob Rigney (Notre Dame Law School J.D., 1973) and my mother Mimi Rigney for
their continued love and encouragement.
1 Alan D. DeSantis et al., Illicit Use of Prescription ADHD Medications on a College
Campus: A Multimethodological Approach, 57 J. AM. COLL. HEALTH 315, 319 (2008).
Mitch’s comment mimics that of many of his classmates surveyed during the study.
Students regularly misuse/abuse Adderall for academic purposes. Id. at 317–19.
2 Margaret Talbot, Brain Gain, THE NEW YORKER (Apr. 27, 2009), http://www.
newyorker.com/reporting/2009/04/27/090427fa_fact_talbot#ixzz1dtS6kewo (“The
demand is certainly there: from an aging population that won’t put up with memory
loss; from overwrought parents bent on giving their children every possible edge;
from anxious employees in an efficiency-obsessed, BlackBerry-equipped office cul-
ture, where work never really ends.”).
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viduals, particularly students, can obtain it, through a diagnosis or illegal
procurement, is alarming and presents ethical issues.  Various solutions,
including random drug testing, heightened disciplinary procedures, and
education programs, have been proposed but do not attack the crux of the
issue.  Instead, this Note posits that to stem the abuse of ADHD medications
in academic settings, the Individuals with Disabilities in Education Act
(IDEA) should be amended to include ADHD as a specific learning disability
and to develop a mandatory standardized diagnostic test that must be per-
formed prior to the diagnosis of ADHD and the prescribing of Adderall that
focuses on the adverse educational effect the disorder has on individuals.
Currently, individuals can obtain an ADHD diagnosis and an Adderall
prescription without much effort by meeting highly subjective criteria.  By
addressing the high rate of ADHD diagnoses and the ease with which this
Schedule II Controlled Substance is obtained, only those requiring the drug
will be able to obtain it and those seeking a competitive edge will be out of
luck.  This Note will proceed in five parts.  Part I will identify background
information on ADHD including diagnosis and treatment.  Part II will
address the current problem surrounding ADHD medications, specifically
Adderall, focusing on the misuse/abuse on college and university campuses.
Part III will discuss the Individuals with Disabilities in Education Act
(IDEA) as well as § 504 of the Rehabilitation Act and the services provided
to students with disabilities and/or ADHD.  Part IV will propose a two-
pronged solution to the overabundance of Adderall and the subsequent mis-
use by students.  By amending IDEA and implementing a standard diagnos-
tic test for ADHD, access to Adderall will decrease and the potential for abuse
will be greatly lowered.  Finally, Part V will address the implications of this
alteration as well as aspects that cannot be addressed by a legislative man-
date.  The inclusion of ADHD as an enumerated learning disability under
IDEA combined with a standardized identification and diagnosis procedure
will allow individuals suffering from ADHD to receive appropriate treatment
while preventing the illegal use of Adderall by those seeking an academic
boost.
I. THE ADHD EPIDEMIC: DIAGNOSIS & TREATMENT
“The drugging of children for A.D.H.D. has become an
epidemic.”3
Attention Deficit Hyperactivity Disorder (ADHD) is one of the
most common neurobehavioral disorders diagnosed in children that
3 Peter R. Breggin, A Misdiagnosis, Anywhere, N.Y. TIMES (Oct. 13, 2011, 8:52
P.M.), http://www.nytimes.com/roomfordebate/2011/10/12/are-americans-more-
prone-to-adhd/adhd-is-a-misdiagnosis (arguing that ADHD symptoms “are the sponta-
neous behaviors of normal children” and when they become age inappropriate, “the
potential causes are limitless”).
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can persist into adulthood.4  Since its induction into the American
Psychiatric Association’s (APA) Diagnostic and Statistical Manual-IIIR
(DSM-IIIR) in 1987 and its replacement of Attention Deficit Disorder
(ADD) in the DSM-IV in 1994, ADHD diagnoses have risen an average
5.5% per year from 2003–2007.5  ADHD manifests in various types
dependent upon the primary behavior exhibited.6  Currently, about
3–7% of school-age children suffer from ADHD; however, since 2007,
about 9.5% of children aged four to seventeen have been diagnosed
with the disorder.7  In addition, though the disorder primarily
appears in childhood, many older students and adults have been diag-
nosed with ADHD.8  Adderall sales increased 3135.6% over a four year
period from 2002–2006.9  In a study conducted at the University of
New Hampshire, researchers discovered that 50% of the students were
first diagnosed with an attention disorder while in high school or
college.10
4 CTR. FOR DISEASE CONTROL, Attention Deficit/Hyperactivity Disorder (ADHD): Facts
About ADHD, http://www.cdc.gov/ncbddd/adhd/facts.html (last visited Nov. 12,
2012) [hereinafter CDC Facts About ADHD].
5 CTR. FOR DISEASE CONTROL, Attention Deficit/Hyperactivity Disorder (ADHD): Data
& Statistics, http://www.cdc.gov/ncbddd/adhd/data.html (last visited Nov. 12, 2012)
[hereinafter CDC Data About ADHD].
6 AM. PSYCHIATRIC ASS’N, DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISOR-
DERS 87, 93 (4th ed., text rev. 2000) [hereinafter DSM-IV-TR].  The DSM-IV-TR spells
out four subtypes of ADHD: combined, predominantly inattentive, predominantly
hyperactive-impulsive, and not otherwise specified.
7 CDC Data About ADHD, supra note 5 (noting that the DSM-IV-TR cites 3–7% of
children suffer from ADHD while parents report about a 9.5% rate of diagnosis); see
also Ethan Watters, An Expression of Our Culture, N.Y. TIMES (Oct. 13, 2011, 2:23 P.M.),
http://www.nytimes.com/roomfordebate/2011/10/12/are-americans-more-prone-
to-adhd/american-culture-and-adhd (discussing various reasons why there “might be
. . . an upwelling of psychopathology”).
8 See Linda Carroll, Adults Who Claim to Have ADHD?  One in Four May Be Faking
It, MSNBC.COM (Apr. 25, 2011, 8:59 A.M.), http://www.msnbc.msn.com/id/427101
78/ns/health-addictions/t/adults-who-claim-have-adhd-may-be-faking-it/
(“[B]etween 2 percent and 4 percent of the adult population is estimated to have
ADHD . . . .”).
9 Joel Garreau, A Dose of Genius, WASH. POST (June 11, 2006), http://www.
washingtonpost.com/wp-dyn/content/article/2006/06/10/AR2006061001181.html
(noting that a reason for the increase is that Adderall is “the winner’s edge—the
difference between a 3.8 average and a 4.0, maybe their ticket to Harvard Law—these
‘brain steroids’ can be purchased on many campuses for as little as $3 to $5 per pill,
though they are often obtained free from friends with legitimate prescriptions”).
10 Barbara Prudhomme White et al., Stimulant Medication Use, Misuse, and Abuse in
an Undergraduate and Graduate Student Sample, 54 J. AM. COLL. HEALTH 261, 265 (2006).
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Because there is no known cause for the disorder,11 there is not
an objective and standardized mechanism for diagnosing individuals
with ADHD.12  As specified by the American Academy of Pediatrics
(AAP) in its diagnostic guideline, other diagnostic tests “contribute
little to establish[ ] the diagnosis of ADHD.”13  Since the discovery of
the disorder, the diagnostic criteria have evolved with guidelines
issued by both the APA and the AAP.  The APA’s DSM-IV-TR estab-
lished criteria to be utilized by medical professionals when diagnosing
ADHD.14  The APA’s Diagnostic Guideline outlines the following fac-
tors: the persistence of symptoms of either inactivity or hyperactivity/
impulsivity for a period of at least six months—symptoms which must
be evaluated by parents or educators as many symptoms do not pre-
sent in a clinical environment; the manifestation of symptoms prior to
age seven; the presence of symptoms in two or more settings and
“clear evidence of interference with developmentally appropriate
social, academic, or occupational functioning.”15  The most important
provision of the DSM-IV-TR states that children who meet the diag-
nostic criteria for the behavioral symptoms of ADHD but who demon-
11 NAT’L RESOURCE CTR. ON ADHD, About AD/HD, http://www.help4adhd.org/
en/about/causes (last visited Nov. 12, 2012) (“Although precise causes have not yet
been identified, there is little question that heredity makes the largest contribution to
the expression of the disorder in the population.  In instances where heredity does
not seem to be a factor, difficulties during pregnancy, prenatal exposure to alcohol
and tobacco, premature delivery, significantly low birth weight, excessively high body
lead levels, and postnatal injury to the prefrontal regions of the brain have all been
found to contribute to the risk for AD/HD to varying degrees.”); see also FRANCIS
FUKUYAMA, OUR POSTHUMAN FUTURE 47 (2002) (“It is a pathology recognized only by
its symptoms.”).
12 See Craig S. Lerner, “Accommodations” for the Learning Disabled: A Level Playing
Field or Affirmative Action for Elites?, 57 VAND. L. REV. 1043, 1068 (2004) (“What is the
difference, then, between the ordinary mix of mind-wandering, exuberance, and
boredom that is part and parcel of ‘growing up,’ and the abnormal inattentiveness
and jitteriness that merits accommodation and even medication?”).
13 AM. ACAD. OF PEDIATRICS, CLINICAL PRACTICE GUIDELINE: DIAGNOSIS AND EVALU-
ATION OF THE CHILD WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER 1167 (2000)
[hereinafter AAP PRACTICE GUIDELINE].  The tests discredited by the AAP include
blood lead levels, thyroid levels, and brain wave assessments. Id.
14 See DSM-IV-TR, supra note 6, at 85–93.
15 Id. at 85–88.  This is a change from the previous editions where symptoms were
those that should “appear in most situations, including at home, in school, at work,
and in social situations . . . .” AM. PSYCHIATRIC ASS’N, DIAGNOSTIC AND STATISTICAL
MANUAL OF MENTAL DISORDERS 50 (3d ed., rev. 1987) [hereinafter DSM-III-R]; see
Doris Derelian, The Legal Yin and Yang of Attention Deficit/Hyperactive Disorder, 5 U.C.
DAVIS J. JUV. L. & POL’Y 245, 250 (2001) (“This liberalization of criteria means greater
numbers of children (and adults) carry this diagnosis in today’s schools and
workplaces.”).
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strate no functional impairment do not meet the diagnostic criteria
for ADHD.16
The AAP’s clinical practice evidence-based guideline17 outlines
the diagnostic and evaluative techniques that should be utilized in the
process of diagnosing a child with ADHD.  This guideline encom-
passes six recommendations including the satisfaction of the DSM-IV
criteria.18  The recommendations are as follows:
16 DSM-IV-TR, supra note 6, at 93.  This provision will feature prominently in my
argument that without the adverse effect on education, specifically school perform-
ance, a diagnosis of ADHD should not be proscribed by a health care professional.
See infra Part IV.
17 AAP PRACTICE GUIDELINE, supra note 13.
18 The DSM-IV-TR Criteria provide these factors:
A. Either (1) or (2)
(1) six (or more) of the following symptoms of inattention have persisted for
at least 6 months to a degree that is maladaptive and inconsistent with devel-
opmental level:
Inattention
(a) often fails to give close attention to details or makes careless mistakes in
schoolwork, work, or other activities
(b) often has difficulty sustaining attention in tasks or play activities
(c) often does not seem to listen when spoken to directly
(d) often does not follow through on instructions and fails to finish school-
work, chores, or duties in the workplace (not due to oppositional behavior
or failure to understand instructions)
(e) often has difficulty organizing tasks and activities
(f) often avoids, dislikes, or is reluctant to engage in tasks that require sus-
tained mental effort (such as schoolwork or homework)
(g) often loses things necessary for tasks or activities (e.g., toys, school assign-
ments, pencils, books, or tools)
(h) is often easily distracted by extraneous stimuli
(i) is often forgetful in daily activities
(2) six (or more) of the following symptoms of hyperactivity-impulsivity have
persisted for at least 6 months to a degree that is maladaptive and inconsis-
tent with developmental level:
Hyperactivity
(a) often fidgets with hands or feet or squirms in seat
(b) often leaves seat in classroom or in other situations in which remaining
seated is expected
(c) often runs about or climbs excessively in situations in which it is inappro-
priate (in adolescents or adults, may be limited to subjective feelings of
restlessness)
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Recommendation 1: In a child six to twelve years old who presents
with inattention, hyperactivity, impulsivity, academic underachieve-
ment, or behavior problems, primary care clinicians should initiate
an evaluation for ADHD.
Recommendation 2: The diagnosis of ADHD requires that a child
meet DSM-IV criteria.
Recommendation 3: The assessment of ADHD requires evidence
directly obtained from parents or caregivers regarding the core
symptoms of ADHD in various settings, the age of onset, duration of
symptoms, and degree of functional impairment.
Recommendation 4: The assessment of ADHD requires evidence
directly obtained from the classroom teacher (or other school pro-
fessional) regarding the core symptoms of ADHD, the duration of
symptoms, the degree of functional impairment, and coexisting
conditions.  A physician should review any reports from a school-
based multidisciplinary evaluation where they exist, which will
include assessments from the teacher or other school-based
professional.
Recommendation 5: Evaluation of the child with ADHD should
include assessment for coexisting conditions.
Recommendation 6: Other diagnostic tests are not routinely indi-
cated to establish the diagnosis of ADHD.19
(d) often has difficulty playing or engaging in leisure activities quietly
(e) is often ‘on the go’ or often acts as if ‘driven by a motor’
(f) often talks excessively
Impulsivity
(g) often blurts out answers before questions have been completed
(h) often has difficulty awaiting turn
(i) often interrupts or intrudes on others (e.g., butts into conversations or
games)
B. Some hyperactive-impulsive or inattentive symptoms that caused impair-
ment were present before age 7 years.
C. Some impairment from the symptoms is present in two or more settings
(e.g., at school [or work] and at home).
D. There must be clear evidence of clinically significant impairment in
social, academic, or occupational functioning.
E. The symptoms do not occur exclusively during the course of a Pervasive
Developmental Disorder, Schizophrenia, or other Psychotic Disorder and
are not better accounted for by another mental disorder (e.g., Mood Disor-
der, Anxiety Disorder, Dissociative Disorder, or Personality Disorder).
DSM-IV-TR, supra note 6, at 92–93.
19 AAP PRACTICE GUIDELINE, supra note 13, at 1160–68.
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The first recommendation specifically mentions “academic
underachievement” as a factor while the following recommendations
rely on data obtained from the home and school environments and
provide for the identification of other disorders.20  By identifying
other disorders—primarily “conduct and oppositional defiant disor-
der, mood disorders, anxiety disorders, and learning disabilities”—
health care professionals can recommend special education services
that are tailored to the coexisting disability rather than only to
ADHD.21
The AAP addresses the limited scope of the DSM-IV-TR criteria in
effectively diagnosing ADHD,22 again reinforcing the subjective
nature of the process.  As highlighted in Recommendation 2,
“[f]urthermore, the behavioral characteristics specified in the DSM-
IV[-TR], despite efforts to standardize them, remain subjective and
may be interpreted differently by different observers.”23  The subjec-
tive nature of the diagnosis and the failure to have a mandatory proce-
dure for diagnosis are major factors in the rise of ADHD medication
access by non-sufferers.  A key component that is required by the
DSM-IV-TR, yet is only part of the guideline, is that there must be
some adverse impact upon the individual in a social, academic, or
occupational environment.
Though these two prominent guidelines exist (in addition to
numerous rating scales),24 studies have shown that medical providers
20 Id.  Much of the information utilized in making a diagnosis is obtained from
parents and teachers.  Recommendation 3 utilizes “evidence directly obtained from
parents or caregivers regarding the core symptoms of ADHD in various settings, the
age of onset, duration of symptoms, and degree of functional impairment.” Id. at
1163.  Recommendation 4 utilizes, “evidence directly obtained from the classroom
teacher (or other school professional) regarding the core symptoms of ADHD, the
duration of symptoms, the degree of functional impairment, and coexisting condi-
tions.” Id. at 1165.  The AAP also provides a clinical algorithm within its criteria out-
lining the process for diagnosis.  This algorithm includes the DSM-IV criteria,
reiterating that symptoms must be present in more than one setting and last for
longer than six months. Id. at 1162 tbl.1.
21 Id. at 1166.
22 Given the lack of methods to confirm the diagnosis of ADHD through other
means, it is important to recognize the limitations of the DSM-IV TR definition. Id. at
1162.
23 Id. at 1163.
24 AM. ACAD. OF CHILD AND ADOLESCENT PSYCHIATRY (AACAP) OFFICIAL ACTION,
Practice Parameter for the Assessment and Treatment of Children and Adolescents with Atten-
tion-Deficit/Hyperactivity Disorder, 46 J. AM. ACAD. CHILD ADOLESCENT PSYCHIATRY 894,
899 (2007) [hereinafter AACAP Practice Parameter] (discussing a practice parameter
that provides information on the clinical evaluation, research, and treatment of
ADHD).
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do not routinely follow either the AAP or APA’s standards for diagnos-
ing ADHD.25  A 2002 study of Michigan primary care physicians,
found that only 25.8% utilized all “4 diagnostic components in the
survey.”26  Though a majority of physicians were familiar with the
guidelines, few utilized the DSM-IV-TR criteria routinely in practice.27
Many selected a few of the recommendations promulgated by the AAP
but adherence to the Clinical Algorithm for diagnosing ADHD was
quite low.28  Though the guidelines were not followed as specified by
the AAP, “[n]early every (97.8%) respondent had prescribed a medi-
cation for ADHD in the past year.”29  Physicians, especially primary
care doctors, are faced with overcrowded waiting rooms, short
appointments, and a variety of other factors that prevent a thorough
evaluation prior to diagnosis.  In addition, the multi-step process for
diagnosis places a strain on physicians and because the procedures are
simply guidelines, many doctors circumvent them.  Furthermore, the
need for concert between educators, parents, and health care profes-
sionals in order to ascertain an individual’s diagnosis consumes more
time than a one visit consultation.  The lack of a standardized and
mandatory procedure for physicians allows the ADHD diagnosis and
medication to be easily obtained by both sufferers and non-sufferers
alike.
Another issue contributing to this problem encompasses individ-
uals who fake ADHD symptoms to obtain the ADHD diagnosis.  Some
individuals desire an ADHD diagnosis for educational assistance such
25 Laurel K. Leslie et al., Implementing the American Academy of Pediatrics Attention-
Deficit/Hyperactivity Disorder Diagnostic Guidelines in Primary Care Settings, 114 PEDIATRICS
129 (2004); Jerry L. Rushton et al., Use of Practice Guidelines in the Primary Care of Chil-
dren with Attention-Deficit/Hyperactivity Disorder, 114 PEDIATRICS e23, e23 (2004) (This
“study sought 1[.] to describe primary care diagnosis and management of ADHD, 2[.]
to determine whether the care is in accordance with American Academy of Pediatrics
(AAP) practice guidelines, and 3[.] to describe factors associated with guideline
adherence.”).
26 Rushton, supra note 25, at e23.
27 Id. at e24–e25.  This presents the primary problem with diagnosing ADHD.
Physicians and other health care professionals are focusing more on the subjective
parent/teacher rating scales rather than the APA’s criteria—specifically the provision
that requires an impairment in social, occupational, or academic functioning.
28 Id. at e23.
29 Id. at e24; see also Prescribed Stimulant Use for ADHD Continues to Rise Steadily,
NAT’L INST. OF MENTAL HEALTH, (Sept. 28, 2011), http://www.nimh.nih.gov/science-
news/2011/prescribed-stimulant-use-for-adhd-continues-to-rise-steadily.shtml [herein-
after Press Release] (“Stimulant medications work well to control ADHD symptoms,
but they are only one method of treatment for the condition.  Experts estimate that
about 60 percent of children with ADHD are treated with medication.” (quoting
Benedetto Vitiello, M.D.)).
\\jciprod01\productn\N\NDL\88-2\NDL211.txt unknown Seq: 9 28-JAN-13 17:02
2012] a  new  prescription  for  adhd  medication  abuse 1041
as extra time on tests and assignments or additional assistance in the
classroom.30  “Students may also be motivated to exaggerate or feign
symptoms in an effort to obtain stimulant medication, either as a
study aid or for recreational purposes as an inexpensive, prescription-
based alternative to cocaine.”31  Because the symptoms of ADHD are
undetectable by a specific medical test, they are easily manufactured
by individuals, especially those with the motivation to secure neuro-
enhancing medication.32  In a similar fashion, because ADHD symp-
tom checklists do not incorporate mechanisms for identifying those
who exaggerate or fake symptoms, it is relatively simple for adults
and/or children to look at criteria from the DSM-IV-TR or the AAP
Guideline and provide answers that will result in an ADHD diagno-
sis.33  Studies have shown “that symptom checklists for ADHD lack
specificity and are prone to over-identifying both students at the post-
secondary level and adults in the general population as having ADHD
when they do not.”34  Criteria for evaluation are posted on numerous
websites including the National Institutes of Health (NIH) and the
AAP, providing a wealth of information for individuals looking to
obtain an ADHD diagnosis and treatment plan.35  Moreover, because
30 A primary motivation for obtaining the diagnosis of ADHD originates with
securing extra-time on tests including admissions tests to secondary education institu-
tions. See Melana Zyla Vickers, A Role in Admissions, N.Y. TIMES (Oct. 12, 2011), http:/
/www.nytimes.com/roomfordebate/2011/10/12/are-americans-more-prone-to-
adhd/the-role-of-adhd-diagnoses-in-college-admissions (“[T]here is [a] small subset
of cases involving parents who may be abusing recent expansions in psychologists’
terminology, as well as in disability law, to seek a diagnosis of attention deficit or
learning disability for their child not because their child is disabled but because the
diagnosis can provide academic advantages.”).
31 Allyson G. Harrison et al., Identifying Students Faking ADHD: Preliminary Findings
and Strategies for Detection, 22 ARCHIVES OF CLINICAL NEUROPSYCHOLOGY 577, 579 (2007)
(citing Sean P. Barrett et al., Characteristics of Methylphenidate Misuse in a University Stu-
dent Sample, 50 CAN. J. PSYCHIATRY, 457–461 (2005)).
32 Id. (“Self-report inventories are notoriously vulnerable to exaggeration or
feigning of symptoms [and] [r]ecent studies demonstrate how simple it is to fake
symptoms of ADHD, especially when filling out self-report checklists.” (internal cita-
tion omitted)); see also, White, et al., supra note 10, at 265 (“This finding [of students
stockpiling ADHD medication] also raises the question of whether students might
fake ADHD or ADD symptoms to obtain stimulants for planned misuse or abuse or
for resale.”).
33 See Harrison et al., supra note 30, at 579.
34 Id. ((citing Allyson G. Harrison, An Investigation of Reported Symptoms of ADHD
in a University Population, 12 ADHD REPORT 6, 8–11 (2004); Barbara S. McCann &
Peter Roy-Byrne, Screening and Diagnostic Utility of Self-Report Attention Deficit Hyperactiv-
ity Disorder Scales in Adults, 45 COMPREHENSIVE PSYCHIATRY 175, 175–183 (2004).
35 How is ADHD Diagnosed?, NAT’L INST. OF HEALTH, http://www.nimh.nih.gov/
health/publications/attention-deficit-hyperactivity-disorder/how-is-adhd-diag-
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physicians do not adhere strictly to the DSM-IV-TR criteria when diag-
nosing ADHD or prescribing medication, students do not necessarily
have to demonstrate an adverse effect upon their education when
presenting symptoms.36
Treatment plans for students suffering from ADHD incorporate a
wide variety of non-medical alternatives to prescribing an ADHD drug.
As highlighted by the Acting Director of the National Institutes of
Mental Health in 2002, “[m]ost often, the first treatment used should
be psychosocial, including behavioral therapy, social skills training,
support groups[,] and parent and educator skills training.”37  Some of
the components of a treatment plan may include: parent training,
classroom supports, behavior modification, and if necessary, medica-
tion.  Behavior modification is the sole nonmedical treatment sup-
ported by a large basis of scientific evidence.38  Behavioral
modifications include assistance with organization, scheduling, stress
relief, and relaxation techniques.39  Though numerous options exist
for the treatment of ADHD, medication provides the fastest and most
effective way to reduce the unwanted behaviors.40  “Adderall over-stim-
nosed.shtml (last visited Nov. 12, 2012); Clinical Practice Guideline, AM. ACAD. OF PEDI-
ATRICS, http://aappolicy.aappublications.org/cgi/content/full/pediatrics;128/5/
1007 (last visited Nov. 12, 2012).  This phenomenon is not limited to students seeking
an edge over classmates. See Carroll, supra note 8 (“Twenty-two percent of adults in
the study who claimed they suffered from attention-deficit/hyperactivity disorder
tried to skew test results to make their symptoms look worse, according to a new
report based on the medical records of 268 patients and published in the journal The
Clinical Neuropsychologist.”).
36 See Carroll, supra note 8 (“‘I had a patient who was prescribed Adderall by
another doctor,’ one physician wrote.  ‘I asked her [for] her medical history pertain-
ing to ADD.  She explained how she had difficulty concentrating at home and how
the meds had helped her maintain the A grades she had been having all along.’”).
37 Attention Deficit/Hyperactivity Disorder—Are We Overmedicating Our Children?:
Hearing Before the H. Comm. on Gov’t Reform, 107th Cong. 72 (2002) (statement of Rich-
ard Nakamura, Acting Director, National Institute of Mental Health, U.S. Dept. of
Health and Human Services).
38 Behavioral Treatment, NAT’L RESOURCE CTR. ON ADHD, http://www.help4adhd.
org/en/treatment/behavioral (last visited Nov. 12, 2012).
39 See Behavioral Treatments for ADHD, CLEVELAND CLINIC, http://my.cleveland
clinic.org/disorders/attention_deficit_hyperactivity_disorder/hic_behavioral_treat
ments_for_adhd.aspx (last visited Nov. 12, 2012).
40 See Amanda Slater & Ronald E. Reeve, The “Tug-Of-War” Over Attention-Deficit
Hyperactivity Disorder: Balancing the Interests of Parents and Schools (and Don’t Forget the
Kids), 27 DEV. MENTAL HEALTH L. 1, 4 (2008) (“Indeed, numerous studies conducted
across a [wide] range of settings have found that stimulant medications effectively
reduce the core symptoms of ADHD.” (citing studies from the American Academy of
Child and Adolescent Psychitary and the New England Journal of Medicine)); see also
AACAP Practice Parameters, supra note 24, at 903 (discussing research reviews of phar-
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ulates the brain allowing for super-enhanced focus with a simple
pill.”41  Adderall (Amphetamine-dextroamphetamine) is the most
common ADHD psycho-stimulant prescribed.42  Since its approval by
the Food and Drug Administration in 1996, its usage has steadily
increased.43  “Amphetamines, such as Adderall and Ritalin, mimic the
dopamine neurotransmitter in the brain,”44 and it has a time-release
formula that allows for an individual to be medicated for an entire
day, a change from previous intermediate-release formulas that
required multiple dosages.45  Adderall is also listed as a Schedule II
Drug in the Controlled Substances Act which provides:
macological and non-pharmacological treatments and noting “the superiority of the
stimulant over the nondrug treatment”).
41 Jennifer Schiffner, Harder, Better, Faster Stronger: Regulating Illicit Adderall Use
Among Law Students and Law Schools 2 (January 2010) (unpublished manuscript) avail-
able at http://works.bepress.com/jennifer_schiffner/1 (emphasis removed); see infra
Part I for a discussion of health care professionals’ tendency to prescribe medication
for ADHD sufferers.
42 See Dextroamphetamine and Amphetamine, NAT’L INST. OF HEALTH U.S. NATIONAL
LIBRARY OF MEDICINE, http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000166/#
(last visited Nov. 12, 2012).  The combination of dextroamphetamine and ampheta-
mine are classified as central nervous system stimulants that alter natural substance
amounts within the brain.  Ritalin (Methylphenidate) was the drug of choice for
ADHD treatment prior to Adderall but was found to be less effective in controlling
the negative behaviors of ADHD. See William E. Pelham, et al, A Comparison of Ritalin
and Adderall: Efficacy and Time-Course in Children With Attention-Deficit/Hyperactivity Disor-
der, 103 PEDIATRICS 1, 1 (1999) (“The doses of Adderall that were assessed produced
greater improvement than did the assessed doses of Ritalin, particularly the lower
dose of Ritalin, on numerous but not all measures.”).
43 See Garreau, supra note 9 (“Total sales have increased by more than 300 per-
cent in only four years, topping $3.6 billion last year . . . .”).
44 Shawn Romer, Note, Combatting the Unfair Competitive Edge: Random Drug Testing
Should Be Implemented in Standardized Testing to Deter Illicit and Unfair Use of Prescription
Stimulants, 21 J.L. & HEALTH 151, 156 (2008) (citing Nora Volkow et al., Evidence That
Methylphenidate Enhances the Saliency of a Mathematical Task by Increasing Dopamine in the
Human Brain, 161 AM. J. PSYCHIATRY 1173–80 (2004)).  Volkow also notes that
increased dopamine levels correlate with a heightened interest and focus in the task
at hand which explains the augmented academic functioning. Id. at 1173, 1179; see
also Jessica Feinstein, Adderall: The Academic Steroid, YALE DAILY NEWS (Jan. 24, 2005),
http://www.yaledailynews.com/news/2005/jan/24/adderall-the-academic-steroid/
(“It comes in dosages of 5, 10, 20, 25[,] and 30 milligrams, is relatively inexpensive
and lacks both the harsh up and down—as well as the street stigma—of the better-
known ADHD drug Ritalin.”)
45 See AACAP Practice Parameter, supra note 24, at 904 (2007) (“Immediate-release
stimulant medications have the disadvantage that they must be taken two to three
times per day to control ADHD symptoms throughout the day.”).  Extended release
formulas allow for medication to be released at a gradual rate, controlling how much
medication enters the body.  Long-acting formulas allow the medication to remain in
the body for longer periods of time. Attention-Deficit/Hyperactivity Disorder, NAT’L INST.
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(2) Schedule II.—
(A) The drug or other substance has a high potential for abuse.
(B) The drug or other substance has a currently accepted medical
use in treatment in the United States or a currently accepted medi-
cal use with severe restrictions.
(C) Abuse of the drug or other substances may lead to severe psy-
chological or physical dependence.46
“[P]ossession of Schedule II drugs can result in up to one year in
prison and a maximum fine of $1,000 for the first offense.”47  Because
of Adderall’s placement in the Schedule II category, the Attorney
General issues an annual quota and drug manufacturers apply for a
certain portion of the quota.48  Adderall also has “the desired effect”
of enhancing concentration and energy levels on any user regardless
of the presence of ADHD symptoms and/or a diagnosis.49  Any user
can acquire a “super human ability to focus for long periods of time,”
OF MENTAL HEALTH,http://www.nimh.nih.gov/health/publications/attention-deficit-
hyperactivity-disorder/complete-index.shtml#pub6 (last visited Nov. 12, 2012).
46 Controlled Substances Act, 21 U.S.C. § 812(b)(2) (2006).  Other drugs
included under Schedule II are cocaine (and its derivatives) as well as opium and
opiates.  21 U.S.C. §812(c) (2006); see Ritalin among Youth: Examining the Issues and
Concerns, Before the Subcomm. on Early Childhood, Youth, and Families of the Comm. on Educ.
and the Workforce, 106th Cong. (2000) (statement of Terrence Woodworth, Deputy
Director, Office of Diversion Control, Drug Enforcement Agency Office of Diversion
Control, Drug Enforcement Agency), available at http://commdocs.house.gov/com-
mittees/edu/hedcew6-109.000/hedcew6-109.htm (“[Adderall has been classified
under] Schedule II of the CSA since 1971.  Schedule II of the CSA contains those
substances that have the highest abuse potential and dependence profile of all drugs
that have medical utility.”).
47 See Romer, supra note 44, at 157–58 (citing 21 U.S.C.S. § 844 (LexisNexis
2006)).  Romer addresses the abuse of prescription stimulants upon entrance exams
for educational institutions and proposes drug testing as a solution. See infra Part IV.
48 21 U.S.C. § 826 (2006).  In May 2011, an Adderall shortage was reported by the
Wall Street Journal. See Peter Loftus, Attention Disorder Drug Shortage Prompts Finger-
Pointing, WALL ST. J., (May 5, 2011), available at http://online.wsj.com/article/
SB10001424052748703992704576305482186274332.html.  The shortage has contin-
ued through the fall and affected both legal and illegal use of the drug. See  Amanda
Gardner, ADHD Drug Shortage Has Patients, Parents Scrambling, HEALTHDAY, May 11,
2011, http://health.usnews.com/health-news/family-health/brain-and-behavior/arti-
cles/2011/05/12/adhd-drug-shortage-has-patients-parents-scrambling; Foster
Kramer, The Great Adderall Shortage of 2011 Rages On, N.Y. OBSERVER, (Nov. 16, 2011),
http://www.observer.com/2011/11/adderall-shortage-2011-new-york-city-11152011/
;.
49 Lerner, supra note 12, at 1069 (quoting SUZANNE H. STEVENS, THE LD CHILD
AND THE ADD CHILD: WAYS PARENTS AND PROFESSIONALS CAN HELP 176 (1996)).
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only contributing to the widespread abuse of these drugs in post-sec-
ondary education and beyond.50
II. ONE PILL A DAY KEEPS FAILURE AWAY?: ADDERALL MISUSE &
ABUSE IN ACADEMICS
“I’m constantly being bombarded with requests.  People can
get desperate.”
—Libby51
Alcohol use by college students has continued at a steady pace in
recent years, yet “nontherapeutic use of prescription drugs has
soared—now second only to marijuana as a form of illicit drug use.”52
Because Adderall produces positive effects, especially in an academic
setting, the potential for misuse and abuse is very high.  Students with-
out the disorder take advantage of the cognitive enhancement Adder-
all provides to those diagnosed with ADHD: increased levels of
concentration and productivity, longer periods of undistracted work,
and the heightened ability to focus.53  Students interviewed about
their illicit use of Adderall during a 2005–06 research study men-
tioned that Adderall was a miracle drug that allowed them to “grasp
ideas . . . be[ ] smarter[, and] . . . recall information quicker.”54  Over-
all, these students, and other participants in similar studies,55 stress
50 Romer, supra note 44, at 155 (quoting Andrew Conte, More Students Abusing
Hyperactivity Drugs, PITTSBURGH TRIB. REV. (Oct. 25, 2004), available at http://
www.pittsburghlive.com/x/pittsburghtrib/print 265518.html.).
51 Andrew Jacobs, The Adderall Advantage: Abuse of Prescription Drugs Is More Than
Common, It’s Hip. But Is It Fair?, N.Y. TIMES (July 31, 2005), http://www.nytimes.com/
2005/07/31/education/edlife/jacobs31.html?pagewanted=all.  Libby was diagnosed
with ADHD when she was in first-grade.  She now sells her pills to classmates as she
only uses Adderall infrequently.  This is a common and frightening occurrence
among higher-education students who were diagnosed with ADHD at a young age
and now “recycle” their pills for other students.
52 Matt Lamkin, A Ban on Brain-Boosting Drugs Is Not the Answer, CHRON. OF
HIGHER EDUC. (Feb. 27, 2011), http://chronicle.com/article/A-Ban-on-Brain-Boost-
ing-Drugs/126523.
53 DeSantis et al., supra note 1, at 317–20.
54 Id. at 319 (internal quotation makes omitted).  This study took place at a large,
public southeastern research university during the 2005–06 school year where the
researchers conducted surveys and in-depth interviews with a select number of stu-
dents. See also Joshua Foer, The Adderall Me: My Romance with ADHD Meds, SLATE MAG.
(May 10, 2005), http://www.slate.com/articles/health_and_science/medi-
cal_examiner/2005/05/the_adderall_me.html (“I felt like I was clearing away under-
brush that had been obscuring my true capabilities.”).
55 See Christian Teter et al., Illicit Use of Specific Prescription Stimulants Among College
Students: Prevalence, Motives, and Routes of Administration, 26 PHARMACOTHERAPY 1501
(2006); Kristy Kaloyanides et al., Prevalence of Illicit Use and Abuse of Prescription Stimu-
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that “ADHD stimulants [are] a salient part of their university culture,”
a “normal” activity that pervades college campuses across the coun-
try.56  At this particular university, 34% of student respondents had
taken Adderall illegally while only 4% had a legitimate prescription
for the medication.57  Though the drive behind illicit use of Adderall
centers on the ability to work harder and essentially become
“smarter,” many students also took advantage of the nonacademic
“perks” the drug can offer, from appetite suppression to additional
energy for long nights spent partying.58
Surprisingly, the supply of this wonder drug is not usually a prob-
lem for students as “the stuff [Adderall] is everywhere.”59  About 89%
of student respondents obtained Adderall from friends who had a
legal prescription, paying anywhere from nothing to ten dollars per
pill.60  Though a small percentage of students have actual prescrip-
tions (in comparison to those using the drug without a prescription),
the supply remains constant because those diagnosed with ADHD take
their medications strategically rather than following the prescribed
dosage.61  Because some of the students surveyed experienced the
adverse side effects (increased heart rate, sweating, loss of appetite,
etc.) of daily use, they simply took the pills as needed and sold or gave
away the surplus.62  Though Adderall is a Schedule II Controlled Sub-
lants, Alcohol and Other Drugs Among College Students: Relationship with Age at Initiation of
Prescription Stimulants, 27 PHARMACOTHERAPY 666 (2007); Sean Esteban McCabe et al.,
Non-Medical Use of Prescription Stimulants Among U.S. College Students: Prevalence and Cor-
relates from a National Survey, 99 ADDICTION 96 (2005).
56 DeSantis et al., supra note 1, at 317.
57 Id. at 316.
58 Id. at 319–20.
59 Id. at 320; see also Garreau, supra note 9 (noting that this abuse goes relatively
unnoticed because “[t]hese ‘drug users may be at the top of the class, instead of the
ones hanging around the corners’” (quoting Richard Restak, a Washington neurolo-
gist and president of the American Neuropsychiatric Association)).
60 DeSantis et al., supra note 1, at 320–21.
61 Id. at 321.
62 Id.  In 2007, the FDA required ADHD drug manufacturers to include informa-
tion about possible psychiatric and cardiovascular side effects, especially  for individu-
als with preexisting heart problems.  The psychiatric problems range from
hallucinations and hearing voices to having suicidal thoughts.  Cardiovascular
problems include increased risk of stroke or heart attack. NAT’L INST. OF MENTAL
HEALTH, ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), http://www.nimh.
nih.gov/health/publications/attention-deficit-hyperactivity-disorder/complete-index.
shtml#pub3 (last visited Nov. 12, 2012).  Other harmful effects include the high
potential for abuse because the medication increases dopamine levels in a similar
fashion to cocaine, leading to increased addiction. Prescription Drug Abuse: What Is
Being Done to Address This New Drug Epidemic?: Hearing Before the Subcomm. on Crim. Jus-
tice, Drug Policy, & Human Res., 109th Cong. 27 (2006).
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stance and can only be obtained in thirty-day doses,63 individuals cre-
ate a large supply by taking the medication on an as-needed basis and
making a profit off non-ADHD users.64  As a surveyed student elo-
quently put it, “[w]hat am I going to do with all those pills?  So I fig-
ure, if I can help out some friends and make some beer money, life is
good.”65  Based on numerous research studies done on college cam-
puses, Adderall misuse and abuse appears to be “stigma free” for both
the suppliers and illicit consumers, providing a barrier to traditional
methods of deterrence.66  Margaret Talbot explored the growing mis-
use of Adderall, noting the ease with which a supply could be
obtained in a New Yorker article.67  Talbot highlighted student com-
ments made at the BoredAt Websites, including, “I have Adderall for
sale 20mg for $15,” and  “I have some Adderall—I’m sitting by room
101.10 in a grey shirt and headphones.”68  During interviews with
Columbia University students in 2005, Andrew Jacobs found that “the
prevailing ethos is that Adderall, the drug of choice these days, is a
legitimate and even hip way to get through the rigors of a hectic aca-
demic and social life.”69
In addition to violating federal law, these individuals are cheating
their way into colleges, graduate schools, and professional careers.  As
Jennifer Schiffner highlights, Adderall abusers gain “[h]eightened
senses during testing time combined with an increased ability to
focus” and can therefore access their “learned knowledge faster and
more efficiently than their peers, giving them a particular advantage
during timed exams.”70  Most admissions programs rely on standard-
ized tests to weigh and differentiate between candidates coming from
63 21 U.S.C. § 812(b)(2) (2006); see SUBSTANCE ABUSE & MENTAL HEALTH SERVS.
ADMIN., Adderall & College Students, http://www.samhsa.gov/samhsanewsletter/Vol-
ume_17_Number_3/Adderall.aspx (last visited Nov. 12, 2012) (“Adderall is among
the group of legally approved drugs classified as having the highest potential for
dependence or abuse.”).
64 U.S. DRUG ENFORCEMENT ADMIN., Drug Scheduling, http://www.justice.gov/
dea/druginfo/ds.shtml (last visited Nov. 12, 2012).
65 DeSantis et al., supra note 1, at 321.
66 Id. at 322.  The idea of actual ADHD sufferers selling or giving their medica-
tion to other students is not only alarming but also unintelligent.  Adderall combats
the impulsivity and inattention that ADHD causes and ADHD sufferers are simply
widening the gap between their learning capacity and those who do not suffer every
time they “share” their extra Adderall.
67 Talbot, supra note 2.
68 Id.
69 Jacobs, supra note 51.
70 Schiffner, supra note 41, at 28.  Schiffner specifically looks at the abuse of
Adderall within a law school setting and examines this abuse in the context of the
ethical standards of the legal profession.
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various schools, backgrounds, and geographical areas.  Yet, with candi-
dates abusing Adderall and other psycho-stimulants during test
administrations, scores can no longer be considered accurate, posing
a problem for schools and students.71 In addition, students continue
to abuse the drugs while enrolled in undergraduate and graduate pro-
grams in order to compete for honors and jobs.  This presents an even
more vexing problem as many programs rank students based on how
they compare to their classmates—a system thrown off by Adderall
misuse and abuse.  As Benedict Carey noted in the New York Times, a
survey conducted by the journal Nature addressed abuse (use for non-
medical purposes) of prescription drugs, including Adderall, by
academia.72 Though the abuse by academia is not as widespread—or
at least has not been determined to be as widespread—the high per-
centage of abuse by current higher education students will most likely
pervade academia and other professions in the near future.73  The
temptation to use Adderall and similar medications stems from a cul-
ture that values cognitive enhancement, possibly more so than physi-
cal beauty or athletic prowess.74  Because obtaining Adderall and
other psycho-stimulants is relatively easy with such a saturated market,
students without disabilities can obtain a “quick-fix” of neuro-
enhancement, propelling them ahead of non-users at a low cost.  In
addition, the abuse of psycho-stimulants by off-label users threatens
the integrity and success of students who truly suffer from ADHD.  By
most standards, it constitutes cheating.  Finally, non-sufferers who mis-
use medications like Adderall can set themselves up for possible
problems with addiction as Adderall has a high likelihood of abuse.75
71 See Greg Crapanzano, Cracking Down on Academic Steroids, CAVALIERDAILY.COM
(Sept. 3, 2007), http://www.cavalierdaily.com/2007/09/03/cracking-down-on-aca-
demic-steroids/ (“It would be almost impossible to say that pulling an all-nighter is
cheating and very difficult to argue that the use of coffee or caffeine pills are methods
of cheating[.]  But using a prescription drug without a doctor’s approval quickly
crosses the line into submitting work that is not of the student’s own merit because
they used an illegal performance enhancer to do the work.  The line of cheating is
not necessarily where the law makes a product illegal, but where the effects of these
drugs become the primary factor in a student’s ability to perform the work.”). But see
Phillip Brettschneider, Adderall Aids Studying, Not Academic Steroids, REDANDBLACK.COM
(Mar. 18, 2010), http://redandblack.com/2010/03/18/adderall-aids-studying-not-
academic-steroids/.
72 Benedict Carey, Brain Enhancement Is Wrong Right?, N.Y. TIMES, Mar. 9, 2008, at
WK1.  This article also discussed the abuse of narcolepsy drugs, specifically Provigil, by
academics and the “era of doping [that] may be looming.” Id.
73 Id.
74 Id.
75 One of the reasons Adderall is a Schedule II substance is because it has the
high likelihood of addiction and abuse.  21 U.S.C. § 812 (2006); see also Carroll, supra
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III. ACCOMMODATING ADHD: CURRENT LEGISLATION
“Statistically speaking, two out of every 30 children in an
elementary level classroom[ ] have an ADD/ADHD
diagnosis.”76
This Part will discuss the passage of IDEA and the implications of
a diagnosis of ADHD.  In addition, it will also highlight the § 504 plan
and its importance in the diagnosis and provision of services to indi-
viduals suffering from ADHD.
The Individuals with Disabilities in Education Act (IDEA) was
enacted “to ensure that all children with disabilities have available to
them a free appropriate public education that emphasizes special edu-
cation and related services designed to meet their unique needs and
prepare them for further education, employment, and independent
living.”77  IDEA covers children between the ages of three and twenty-
one with specifically identifiable disabilities and grants them an educa-
tion in the least restrictive environment possible.78  Students who are
deemed appropriate for services under the act are given an Individual-
ized Education Plan (IEP) that outlines the disability and any services
they will receive while in school.79  To satisfy the requirements of
IDEA, educational personnel must play an active role in determining
if a student has a disability and in administering appropriate services if
specific criteria are satisfied.  Not all students with learning disabilities
are covered under IDEA and therefore do not receive services.  IDEA
defines a student with a disability as one having “mental retardation,
hearing impairments (including deafness), speech or language
impairments, visual impairments (including blindness), serious emo-
tional disturbance (referred to in this chapter as ‘emotional distur-
bance’), orthopedic impairments, autism, traumatic brain injury,
other health impairments, or specific learning disabilities.”80  In addi-
tion, IDEA requires that a student’s disability have an adverse effect
on the child’s academic success in order for educational services to be
provided.81  ADHD does not fall under the narrow scope of enumer-
note 8 (mentioning an individual who abused Adderall to succeed in medical school,
then flunked out because of a subsequent addiction to the medication).
76 Jennifer Orr, Adderall Use a Growing Problem Among Students: Pill-Popping Epi-
demic Spreads to Suffolk, SUFFOLK J. (Apr. 14, 2010), http://suffolkjournal.net/2010/
04/adderall-use-a-growing-problem-among-students/.
77 20 U.S.C. § 1400(d)(1)(A) (2006).
78 20 U.S.C. § 1411(a)(2) (2006).
79 20 U.S.C. § 1414 (2006).
80 20 U.S.C. § 1401(3)(A)(i) (2006).
81 20 U.S.C. § 1401(3)(A)(ii) (2006).
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ated disabilities outlined in IDEA; students suffering from this disor-
der can obtain services under the category of Other Health
Impairments if the ADHD symptoms “adversely affect[ ] a child’s edu-
cational performance.”82  Students who are denied services under
IDEA may still qualify under § 504 of the Rehabilitation Act.83  In
order to obtain § 504 services, students must show that their impair-
ment “substantially limits one or more . . . life activities,”84 requiring
that the “disability interferes with” a major life function including
breathing, seeing, learning, hearing, speaking, working, and perform-
ing manual tasks.85  However, placement in this category does not pro-
vide a clear method for diagnosing ADHD—it simply allows students
with this diagnosis, who would otherwise be denied services under
IDEA, to receive services in an educational setting.  Federal special
education laws allow for school personnel to initiate an evaluation for
a learning disability or ADHD,86 but this is simply for the allocation of
services within the school setting.  The actual medical diagnosis and
treatment with psychotropic drugs—the main concern of this Note—
fall outside the purview of IDEA and § 504, as neither statute focuses
on the medical diagnosis.  By connecting the diagnosis of ADHD with
federal special education laws, we can achieve consistency in diagnosis
and effective treatment and thwart off-label usage.
IV. A NEW KIND OF PRESCRIPTION: ALTERING
THE DIAGNOSTIC PROCEDURES
“There are big cultural pressures to get these drugs. . . .
That’s because everyone is in an arms race of
accomplishment.”87
As mentioned above, the misuse and abuse of ADHD medications
is a large problem affecting various areas of society from young school
children to the adult workforce.88  Abuse and misuse present ethical
82 34 C.F.R. § 300.8(c)(9)(i) (2009).
83 29 U.S.C. § 794(a) (2006) (providing for nondiscrimination in education for
all individuals).
84 29 U.S.C. § 705(20)(B)(i) (2006).
85 Connie Lenz, Prescribing a Legislative Response: Educators, Physicians, and Psycho-
tropic Medication for Children, 22 J. CONTEMP. HEALTH L. & POL’Y 72, 86 (2005).
86 20 U.S.C. § 1414(b) (2006).
87 Carroll, supra note 8 (quoting Dr. Anjan Chatterjee, a professor of neurology
at the University of Pennsylvania).
88 Amphetamine abuse has been around for many years and not just among the
younger generations. See Foer, supra note 54 (“The drug also has a distinguished
literary pedigree. . . .  James Agee, Graham Greene, and Philip K. Dick all took the
drug to increase their output.  Before the FDA made Benzedrine [an over-the-counter
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issues regarding how society views cognitive enhancement.89  One pri-
mary concern focuses on the unfair professional or academic advan-
tage that non-ADHD sufferers obtain while taking Adderall.90  As
previously discussed,91 Adderall provides all users—those with ADHD
and those without—a heightened ability to focus and complete tasks
at a faster rate.  This increased efficiency is instrumental in an aca-
demic or high-pressured work environment.  Students and profession-
als are usually rewarded through scholarship and bonuses based upon
achievement.  But if the achievement is dependent upon an illegal
prescription, should it be rewarded?92  Should cognitive-enhancement
drugs be an acceptable method of attaining academic success?  Spe-
cific professions might actually benefit from Adderall use, “such as . . .
air-traffic controllers, surgeons and nurses who work long shifts.”93
amphetamine similar to Adderall] prescription-only in 1959, Jack Kerouac got
hopped up on it and wrote On the Road in a three-week ‘kick-writing’ session.
‘Amphetamines gave me a quickness of thought and writing that was at least three
times my normal rhythm,’ another devotee, John-Paul Sartre, once remarked.”).
Though these Adderall substitutes aided the creative development of these literary
giants, many psychologists and researchers believe that Adderall use stifles creativity.
See Talbot, supra note 2 (“Cognitive psychologists have found that there is a trade-off
between attentional focus and creativity.  And there is some evidence that suggests
that individuals who are better able to focus on one thing and filter out distractions
tend to be less creative.” (quoting Martha Farah, a psychologist at the University of
Pennsylvania and the director of its Center for Cognitive Neuroscience)).
89 See generally Barbara Sahakian & Sharon Morein-Zamir, Professor’s Little Helper,
450 NATURE 1157, 1159 (2007) (presenting ethical dilemmas stemming from cogni-
tive enhancement medications including unfair advantages in academics and the fear
of “an overworked 24/7 society pushed to the limits of human endurance”); Romer,
supra note 44, at 159 (“Anyone [abusing or misusing] prescription stimulants are [sic]
put at an unfair competitive edge vis-à-vis those who take the tests in a legal
manner.”).
90 See Crapanzano, supra note 71 (“Much like baseball’s new rule banning per-
formance-enhancing drugs, Adderall and similar drugs, when used without a prescrip-
tion, violate the tenets of honor because they create an unfair advantage for the users
who are willing to break the law in order to gain an edge.”).
91 See supra Part II.
92 See Nicholas W. Schieffelin, Maintaining Educational and Athletic Integrity: How
Will Schools Combat Performance-Enhancing Drug Use?, 40 SUFFOLK U. L. REV. 959, 974
(2007) (“Students, who illegally use performance-enhancing drugs in classes, exams,
standardized tests, and athletic competition, are cheating the educational system and
other students by gaining an unfair advantage and breaking the law.”); see also
Michelle Trudeau, More Students Turning Illegally to “Smart” Drugs, NAT’L PUB. RADIO
(Feb. 5, 2009), http://www.npr.org/templates/story/story.php?storyId=100254163
(“It takes away your own coping skills and your own ability to evolve your own study
skills and work ethic. So it’s kind of an easy way out.” (quoting a college senior inter-
viewed for the article)).
93 Sahakian & Morein-Zamir, supra note 89, at 1158.
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Some commentators draw correlations between Adderall use and the
consumption of caffeine and other energy drinks94 or the use of
tutors in an academic setting,95 but caffeine is not classified as a
Schedule II substance under the CSA and tutors are not illegal with-
out a valid prescription.  Similarly, not all advantages that individuals
can gain constitute a form of cheating.  An analogy can be drawn to
anabolic steroid use in athletics, where, though steroids increase
strength and size, an athlete’s ability to play depends on skill.  How-
ever, these drugs are banned within athletics through anti-doping reg-
ulations.96 Adderall provides the same advantage within the academic
context—it aids in the ability to focus and study for long periods of
time—yet, in the end, success is dependent upon the student’s knowl-
edge and thinking ability.  If athletic and academic steroids provide
the same advantage, why are athletic steroids stigmatized while aca-
demic ones are lauded and used pervasively?  The carefree,
unprescribed, and “stigma-less” use of cognitive enhancers like Adder-
all among students and adults eviscerates standards of conduct in aca-
demic and professional settings as doping does in the athletic arena.
Because the prevalence of abuse across college campuses in par-
ticular is so high, some colleges and universities have amended their
discipline policies to address the problem.97  Though changes have
94 Id.; see also Lerner, supra note 12, at 1070 (“In fact, students have for some
time recognized that Ritalin [as well as Adderall] stimulates the brain and promotes
alertness more than substitutes such as caffeine and nicotine . . . .”); Schiffner, supra
note 41, at 29 (countering arguments that Adderall is equal to test preparation
courses or tutors by asserting that “[u]nlike the tennis coaches and tutors of oppo-
nents’ queries, Adderall imparts a direct and immediate physical benefit to its user,
allowing them to perform more efficiently”).
95 See Michael Ruse, Are Tutors the Academic Equivalent of Steroids?, CHRON. OF
HIGHER EDUC. (June 10, 2011, 9:04 AM), http://chronicle.com/blogs/brainstorm/
are-tutors-the-academic-equivalent-of-steroids/36121 (pondering the “moral differ-
ence between a baseball player on steroids and a high-school kid stuffed to the gills to
achieve higher results on the SAT’s or grades in class”).
96 See U.S. ANTI-DOPING AGENCY, http://www.usada.org/ (last visited Nov. 12,
2012).  The Agency notes that its mission encompasses “preserv[ing] the integrity of
competition,” which should inspire a legislative response to preserve the integrity of
academic institutions in a similar vein. Id.
97 Duke University has altered its discipline policy to include prescription drug
abuse as cheating rather than just as a drug policy violation.  “[T]he unauthorized use
of prescription medication to enhance academic performance constitutes cheating.”
DUKE UNIV., NOTEWORTHY CHANGES FOR 2011–12 TO THE DUKE COMMUNITY STANDARD
IN PRACTICE: A GUIDE FOR UNDERGRADUATES (2011).  This type of prescription drug
abuse also violates the University of North Carolina’s drug policy. See THE UNIV. OF
N.C. AT CHAPEL HILL, POLICY ON ILLEGAL DRUGS, (2000), available at http://www.unc.
edu/campus/policies/illegal_drugs.html.
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been made to extend the definition of cheating to include the use of
prescription drugs for academic enhancement, these policies will be
incredibly difficult for school officials to enforce.98  Many other solu-
tions have been proposed to manage distinct aspects of this issue from
random drug testing prior to standardized tests,99 more training for
health care professionals about ADHD,100 as well as regulatory mea-
sures for prescriptions.101  One solution that is similar in nature to the
one proposed here recommends that state legislation create and
implement guidelines for physicians in diagnosing ADHD as well as
other neurobehavioral disorders in children.102  A state-centered solu-
98 See Lauren Carroll, Conduct Policy Changes Reflect Drug Abuse, THE CHRONICLE
(Sept. 6, 2011), http://dukechronicle.com/article/conduct-policy-changes-reflect-
drug-abuse.  (“Enforcement is difficult, and the students who proposed this addition
recognize this.  They wanted to at least symbolically make a statement.” (quoting Asso-
ciate Dean of Students and Director of the Office of Student Conduct Stephen Bryan)
(internal quotation marks omitted)); see also Schiffner, supra note 41, at 36–38 (pro-
posing heightened disciplinary consequences for violators as well as drug abuse and
prevention focus groups, student coalitions, and orientation activities to combat the
illegal prescription drug use).
99 See Schieffelin, supra note 924, at 979 (advocating for the expansion of “suspi-
cionless drug testing programs to detect and regulate drugs that deprive un-enhanced
students from enjoying an educational and athletic experience where their skills are
judged on natural ability and not according to what drugs they are abusing”). But see
Lamkin, supra note 52 (arguing that prohibitions and penalties for prescription drug
use is not an adequate solution).
100 See Lenz, supra note 85, at 104 (“Legislation should address training required
for physicians who will diagnose and treat children with ADHD and other
neurobehavioral disorders.  This training should include all facets involved in the
diagnosis and treatment of neurobehavioral disorders, including the prescription of
psychotropic medications as well as alternative treatments.”).
101 DeSantis et al., supra note 1, at 322.  DeSantis proposes focusing on the stu-
dents with actual legal prescriptions of ADHD in combating misuse by non-sufferers.
One component of this solution would be to “limit[ ] the monthly allotment of pills
to 20—except in cases where patients can clearly show the need for daily use. Id.  In
addition, DeSantis also advocates for information programs such as “campus-wide
campaigns that educate the student population about the health risks and legal penal-
ties associated with illegal stimulant use.” Id.; see also White et al., supra note 10, at
266 (“Medical personnel, university leadership, parents, and students should take
steps . . . to ensure that university students are informed about the dangers of stimu-
lant medications . . . .”).  Another solution mentioned by many involves lessening the
demands of the academic environment—however, this is not the answer.  There are
students who can handle rigorous course loads, activities, and personal lives without
dependence upon stimulant medication—success does not (and should not) depend
upon a little orange pill.
102 The idea of legislation requiring guidelines for physicians when diagnosing
ADHD and other neurobehavioral disorders has been suggested. See Lenz, supra note
85, at 104 (arguing that “state law should require state medical boards or panels to
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tion is distinct from the current proposal because it focuses on physi-
cian training and the harmful effects of psychotropic drugs on
children.  The federal standard aims at ensuring accurate diagnosis
across the country rather than on a state-by-state basis as well as
addressing the increased use and abuse among older students.
Though states play an active role in the identification of individuals
with disabilities, a federal standardized test is necessary to adequately
combat the problem of misuse and abuse of ADHD medications.103
In addition, this Note’s proposal is not limited to children diagnosed
with neurobehavioral disorders and prescribed psychotropic medica-
tion.  Instead, the concern lies with older students who manufacture
symptoms or obtain medication for misuse or to pass along to fellow
non-sufferers.  The state legislative solution addresses the concern
that educators require children to be placed on psychotropic medica-
tion without adequate informed consent from parents.104  This Note
argues that because there has been such a drastic increase in the rate
of diagnosis of ADHD in older children as well as adults, in addition
to an increase in the manufacturing of ADHD symptoms,105 health
care professionals should adhere to federally-mandated testing mea-
sures at all age levels to curb incorrect usage of medication.106
This Note proposes an amendment to IDEA to add ADHD to the
list of disabilities covered under the act specifically because it is one of
adopt and implement policies regarding training of physicians who prescribe psycho-
tropic medication as well as guidelines and procedures for diagnosis and treatment”).
103 In addition, there are discrepancies in the prescription of ADHD medications
across age, ethnic, gender, and geographic barriers suggesting that a national
mandatory test is needed to maintain consistency among diagnoses. See Statement of
Terrence Woodworth, supra note 46 (“ARCOS [Automation of Reports and Consoli-
dated Orders System] data indicates that there is wide variability in the use of
methylphenidate and amphetamine from one state to another and from one commu-
nity to another within the states. This variability are noted in a number of data sources
and suggests both under and over-identification of ADHD.”); Press Release, supra
note 29 (“These persistent differences in prescribed stimulant use related to age,
racial and ethnic background, and geographical location indicate substantial variabil-
ity in how families and doctors approach ADHD treatment throughout the United
States.” (quoting Dr. Zuvekas) (internal quotation marks omitted)).
104 See Lenz, supra note 854, at 104–05.
105 See Carroll, supra note 8 (noting that many adults who believe they have ADHD
are struggling “simply [because of] depression, anxiety or lack of sleep” or are having
a difficult time dealing with their workloads and lives (quoting Paul Marshall, a
clinical neuropsychologist with Hennepin Faculty Associates)).
106 A federal diagnostic measure will also aid in curbing post-secondary misuse by
preventing inconsistent diagnostic standards across the nation.
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the most common neurobehavioral disorders in children.107  Though
§ 504 provides for services if an individual’s learning is substantially
impacted by his or her mental or physical impairment—which
includes ADHD108—IDEA specifically requires an adverse effect on
the individual’s education and covers the most widely diagnosed disa-
bilities.  This will alter the current structure of including ADHD under
the umbrella term of Other Health Impairments and reinforce the
requirement of having an adverse effect on education before a diag-
nosis and medication are obtained.  In conjunction with including
ADHD within § 1401 of IDEA, Congress should implement a stan-
dardized diagnostic test for ADHD to be used by health care providers
who diagnose ADHD and prescribe medication in both children and
adults.  This federal measure would go hand-in-hand with IDEA—and
be required for services under IDEA as well as for outside diagnosis—
in that a student may not obtain an ADHD diagnosis or correspond-
ing medication without satisfying the requirements of the diagnostic
test, providing more accuracy in diagnosis and treatment with pre-
scription medications.  This diagnostic test will correlate directly with
the IDEA amendment, as the statute will require satisfaction of the
testing measure prior to both a diagnosis and the rendering of ser-
vices in the academic environment.  Any standardized measure should
be created along the lines of the DSM-IV-TR criteria promulgated by
the APA, a nationally known and well-regarded rubric for psychologi-
cal disorders.  Though guidelines exist for the diagnosis of ADHD,109
they do not demand adherence before medication is prescribed;
instead they are non-mandatory rubrics.  By implementing a
mandatory standardized diagnostic test, physicians will be better able
to identify ADHD symptoms accurately and prescribe medication only
when necessary—cutting off the source of improper use of Adderall
107 See CDC Facts About ADHD, supra note 4.  This may be due to the fact that, as I
am arguing, ADHD is misdiagnosed, and a diagnosis is relatively easy to obtain under
current physician practice.  However, irrespective of this fact, ADHD should be
included under IDEA.  To illustrate, Autism Spectrum Disorders, a specified disorder
under IDEA, occurs in about one percent of children in the United States. Autism
Spectrum Disorders (ASDs), CTRS. FOR DISEASE CONTROL (June 19, 2012), http://www.
cdc.gov/ncbddd/autism/research.html.  ADHD occurs in one in ten children. Mike
Stobbe, 1 in 10 Kids in U.S. Has ADHD, New Study Says, A.P. (Nov. 10, 2010), http://
www.msnbc.msn.com/id/40113826/ns/health-childrens_health/t/kids-us-has-adhd-
new-study-says/.
108 See Protecting Students with Disabilities, Frequently Asked Questions About Section 504
and the Education of Children with Disabilities, U.S. DEP’T OF EDUC. (Mar. 17, 2011),
http://www2.ed.gov/about/offices/list/ocr/504faq.html#protected.
109 See infra Part I.
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and its counterparts.110  Though there is no perfect solution to Adder-
all abuse, by only prescribing medication to individuals who require it,
the amount available for consumption would be limited.  Because
those who obtain an unnecessary prescription tend to use Adderall in
specific circumstances, they have a larger quantity available for sale.
Removing this Adderall supply reduces the opportunities for individu-
als to obtain the pills without a prescription and can curb abuse sub-
stantially.  These proposed mechanisms will prevent students from
obtaining unnecessary medication while also ensuring that students
who truly suffer an adverse educational impact will obtain the services
and medication that they need.  When students are correctly diag-
nosed, the educational system can better serve their needs through
classroom services, and health care professionals can accurately and
safely prescribe medication.  This will also provide a barrier to stu-
dents trying to secure an ADHD diagnosis by “faking” symptoms and
then violating the CSA by distributing medication to others without a
prescription.
In creating a standard diagnostic test for ADHD, educational pro-
fessionals, physicians, and psychologists must collaborate to effectively
identify the primary and essential symptoms necessary for a diagno-
sis.111  The guidelines from both the APA and AAP contain the neces-
sary information for accurate diagnosis.112  By creating a mandatory
procedure to follow prior to diagnosis, individuals truly suffering from
ADHD will be identified and provided services, including medication,
and malingerers will be turned away.  As the DSM-IV-TR criteria are
included in the AAP guideline, this would be the necessary starting
point in finalizing a standardized measure.  As explained above,113
most guidelines identify a variety of factors to be taken into account
when diagnosing ADHD.  These range from parent/teacher surveys,
110 One other component of this standard diagnostic measure should be a validity
scale to screen out those individuals who are faking symptoms. See Harrison et al.,
supra note 31, at 586 (suggesting that there is a need “to develop a validity scale to
embed within a self-report inventory, composed of items that look similar to the symp-
toms of ADHD, and yet are not often endorsed by individuals with this disorder”).
111 This will most likely be a long, protracted process.  However, it is necessary to
ensure accurate diagnosis and treatment especially when ADHD medication is
involved.  The Schedule II classification for the active ingredient in Adderall places an
even higher importance on designing correct prescription procedures. See supra
notes 46–49.
112 Because the AAP Practice Guideline contains the DSM-IV-TR criteria, it mea-
sures displayed behaviors of inattention, hyperactivity, and impulsivity over a specific
period of time in addition to requiring presence of these behaviors in two or more
settings. See DSM-IV-TR, supra note 6, at 92–93.
113 See supra Part I.
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behavior scales, and interviews with the individual all focused on iden-
tifying ADHD outside the biological context.  One factor that must be
included in a new ADHD diagnostic test is the adverse effect on the
child’s education—a factor utilized by both IDEA and § 504 and
included within the DSM-IV-TR and AAP criteria.114
In addition, a new standardized diagnostic test must include a
mechanism for reevaluation of symptoms within a specific time
frame.115  Typically symptoms dissipate as a child reaches adulthood,
though the disorder can persist throughout a person’s lifetime.116
Though this measure will most likely be published and made widely
available to the public, the requirement of the adverse effect on edu-
cation will be an adequate safeguard against manufactured diagnoses.
Students would have to demonstrate a marked decrease in achieve-
ment over a period of time no less than six months in order to obtain
a diagnosis.  For those seeking a cognitive boost without suffering
from ADHD, they would have to perform poorly in school—a contra-
dictory move for a student concerned about academic success.
Since IDEA is a federal mandate for educational institutions, cre-
ating a standardized mechanism for diagnosing and treating ADHD
will aid in the detection and appropriate treatment of children and
adolescents with ADHD.  Because Congress has already placed federal
strictures on the treatment of individuals with disabilities,117 amend-
ing IDEA to enumerate ADHD as a covered disability is merely an
extension of current policy.  This amendment and the creation of a
standardized diagnostic measure will aid in the effectiveness of IDEA
to extend services to those students who need them, while enabling
health care professionals to navigate an increasingly difficult disorder
to identify and treat effectively.
Amending IDEA to include ADHD as an enumerated disability
and to require use of the standardized diagnostic measure—which
itself will demand a showing of an adverse effect on education—will
adequately address the issue of k–12 students misusing or abusing
Adderall.  However, a large segment of the population—college and
university students as well as adults not enrolled in an academic pro-
114 See AAP PRACTICE GUIDELINE, supra note 13; DSM-IV-TR, supra note 6.
115 Rushton et al., supra note 25, at e27 (“[L]ittle attention has been paid to the
ongoing evaluation and long-term treatment of children and adolescents . . . .”).
Therefore, more research is necessary to ensure that those diagnosed with ADHD are
accurately monitored and treated to effectively manage their symptoms.
116 See CDC Facts About ADHD, supra note 4.
117 See 20 U.S.C. § 1400 (2006).
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gram—obtain ADHD diagnoses and medication at a high rate.118  By
standardizing the diagnostic procedures, physicians and health care
professionals can accurately diagnose individuals regardless of age
and restrict the amount of Adderall prescribed.  Though the standard-
ized measure would include a provision mandating that ADHD cause
an adverse effect on one’s education, this can easily be adapted for
adults in the workforce (for instance, requiring a decrease in perform-
ance at work over an extended period).119
V. SIDE EFFECTS: IMPLICATIONS ON MEDICAL PROFESSIONALS
“Ultimately, it’s a clinical diagnosis. You can interpret an individ-
ual patient’s symptoms any way you want.”120Amending IDEA and
implementing a standardized diagnostic test will combat future mis-
diagnosis and abuse of ADHD medications; however, it will not be
able to make a drastic impact upon current misusers and abusers.  In
order to curb current off-label usage, health care professionals should
reevaluate individuals with an ADHD diagnosis and/or a medication
treatment plan to determine if they truly require the ADHD label.
Once the standardized diagnostic measure is in place, physicians will
be able to retest their patients of all ages to screen out individuals who
do not require medication.  For those individuals who already have a
diagnosis of ADHD, a modified version of the diagnostic measure can
be used for reevaluation and an assessment of the current diagnosis.
Rather than requiring these individuals to demonstrate an adverse
effect on education, physicians can evaluate their performance on
attention-related tasks without the use of their prescriptions.  This
modified test can assist physicians in monitoring patients with ADHD
and in correctly re-diagnosing them.
By implementing a national standardized measure, physicians will
lose some discretion in the diagnosis and treatment of ADHD.
Because an ADHD diagnosis (and subsequent treatment with medica-
tion) will require satisfaction of federally mandated standards, health
118 See Garreau, supra note 9 (“[M]ore than 7 million Americans used bootleg
prescription stimulants, and 1.6 million of those users were of student age.”).
119 The measure focuses on an educational impact because the majority of diagno-
ses and prescriptions are obtained by individuals currently enrolled in elementary,
high schools, and post-secondary programs and because the ethical implications are
so high in these environments.  In addition, educational impact can encompass social
impairment as well which can be recognized in adults.  There are various ways to
evaluate adult behavior in the workplace, specifically through social interactions, over-
all focus, attention to detail, and ability to complete tasks.
120 Feinstein, supra note 44 (quoting Dr. Carl Baum, director of the Center for
Children’s Environmental Toxicology at Yale-New Haven Children’s Hospital).
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care professionals will gain a bright-line measure at the expense of
professional decision-making.  However, the diagnostic test does not
require physicians to certify a diagnosis or prescribe medication;
instead it only requires that prior to diagnosing ADHD, the strictures
of the test be satisfied.  After the test is satisfied, a physician can deny
an ADHD diagnosis, choose to prescribe medication, regulate the dos-
age, or devise a different treatment plan.  This standardized test will
simply provide the necessary guidance for medical professionals as
they navigate an uncertain area of psychopathology.  Professionals in
the field will still maintain a level of discretion and judgment when
developing a treatment plan for an individual presenting with the
standardized symptoms of ADHD.
CONCLUSION
Adderall misuse and abuse is increasing across the nation
through both the misdiagnosis of ADHD and the procurement of the
medication illegally.  The cognitive boost that individuals gain while
taking Adderall has driven students, as well as professional adults, to
misuse the drug to gain an advantage in concentration and focus over
non-users.  Though Adderall provides treatment for individuals who
truly suffer from ADHD, its overuse in recent years is problematic and
raises ethical issues for society.  Numerous measures have been pro-
posed to combat this staggering increase in both ADHD diagnoses
and prescriptions for Adderall and its relative drugs.  However, none
of these adequately address the vast nature of the problem and the
need for a federal response.  Because Adderall is a Schedule II drug
under the Controlled Substances Act due to its highly addictive
nature, it is imperative that nationwide standards be adopted and
included under IDEA so that accurate diagnosis and treatment of
ADHD can follow.  Though other neurobehavioral disorders do not
require mandatory diagnostic tests, the medications for these are not
as highly regulated, nor is the abuse level as high as that of Adderall.
By requiring physicians and other health care professionals to follow a
national testing rubric to diagnose, and therefore prescribe, Adderall
and other ADHD medications, individuals who truly suffer from
ADHD will receive the necessary treatment and non-sufferers will be
unable to circumvent the testing procedures to obtain a fake diagnosis
and subsequent medication.  Finally, these measures will begin to
combat the unethical, illegal, and dishonest abuse of ADHD medica-
tions within the academic and professional climate.
\\jciprod01\productn\N\NDL\88-2\NDL211.txt unknown Seq: 28 28-JAN-13 17:02
1060 notre dame law review [vol. 88:2
